A deep dive into CLEAR OUTCOMES and its implications

March 13, 2023 | Webinars on-demand

The Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial will be discussed at ACC.23.
In this webinar, open to EAS scientific and medical community, EAS experts look into what these new results may mean in clinical practice.

Join this EAS webinar to gain understanding of the scientific basis for the study & the role of bempedoic acid in lipid-lowering therapy and CVD management. We will be discussing key messages from the trial results, and exploring the implications of the trial findings on clinical practice.

Webinar Programme

1. Introduction & welcome, by Chair, Lale Tokgozoglu, Turkey
2. Study design, speaker Maciej Banach, Poland
3. CLEAR Outcomes trial – results & key findings, speaker Steve Nicholls, Australia
4. How will this change my clinical practice?, speaker Ulrich Laufs, Germany
5. Panel Discussion: Maciej Banach, Ulrich Laufs, Steve Nicholls, Lale Tokgozoglu & Alberico L. Catapano
6. Wrap up, summary, by Chair Alberico L. Catapano, Italy

EAS have independently created and organised the programme for this webinar. Financial support has been provided by Daiichi-Sankyo.

Alberico L. Catapano

Professor of Pharmacology and Director of the Center of Epidemiology and Preventive Pharmacology at the University of Milan

Lale Tokgözoğlu

MD, FACC, FESC, Professor of Cardiology, Hacettepe University, Ankara, Türkiye

Maciej Banach

MD, PhD, FNLA, FAHA, FESC

Stephen Nicholls

MBBS, PhD

Ulrich Laufs

Chair and Professor of Cardiology at Leipzig University, Germany